News & Media / Newsroom
Alfasoxx (Esoxx) has been awarded the Platinum Ounce (the most prestigious award on the Russian pharmaceutical market) “For the change of treatment paradigm".
New EVF Guidelines publication entitled Management of CVD of lower limbs – Part II reports Sulodexide scientific evidences in the dedicated chapter to Prevention of Post-Thrombotic Syndrome, defining the scheme for best therapeutic use of the drug.
Another way to interact and keep informed about Alfasigma.
At a time when digital is taking on even more importance, the Mexican team completes an important step for its digital presence and to be better known nationally and internationally.
Alfasigma Romania SRL, local subsidiary of Alfasigma group has decided to donate more than 100.000 euros to more than 75 Romanian Hospitals all around the country.
From Italy, with European, Chinese and Iranian partners, the attempt to answer the questions generated by the SARS-CoV-2 virus: a genetic study at the basis of new diagnostic and therapeutic solutions.
[email protected]
+39.051.6489.562
+39.051.6489.884
+39.06.9139.4396
You’re entering Alfasigma global website
I agree